SP-MHCI-1231-3

Islet amyloid polypeptide 64-78, GQVELGGGNAVEVLK

US$507.00

In stock

Description

About Islet amyloid polypeptide 64-78, GQVELGGGNAVEVLK

The Human Islet amyloid polypeptide Peptide (IEDB: 505706) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Islet amyloid polypeptide Peptide, H-GQVELGGGNAVEVLK-OH (Uniprot: P10997 aa: 64-78) from JPT is produced under strict quality control and quality management.

Islet amyloid polypeptide 64-78, GQVELGGGNAVEVLK - Specifications

  • Peptide sequence: H-GQVELGGGNAVEVLK-OH
  • Amount: 10 mg (10 x 1 mg)
  • Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
  • Counterion: TFA
  • Delivery Format: Freeze-dried in glass vial
  • Application(s): T-cell Immunity
  • Condition(s)/Topic(s): Multiple sclerosis
  • Standard Delivery Time: approx. 3 weeks

JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!

Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!

References

References for Islet amyloid polypeptide 64-78, GQVELGGGNAVEVLK

References:
Read References with JPT’s Antigen Peptides

Islet amyloid polypeptide 64-78, GQVELGGGNAVEVLK has been described in:
Pathogenic CD4 T cells in type 1 diabetes recognize epitopes formed by peptide fusion., Science, 2016 (PMID: 26912858.0)< br/>Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes., Nat Med, 2016 (PMID: 27798614.0)< br/>Hybrid Insulin Peptides Are Autoantigens in Type 1 Diabetes., Diabetes, 2019 (PMID: 31175101.0)

Documentation

Documentation for Islet amyloid polypeptide 64-78, GQVELGGGNAVEVLK

Properties

Properties of Islet amyloid polypeptide 64-78, GQVELGGGNAVEVLK

Properties Values
Application: T-cell immunity
Category: Antigen Peptides
Condition / Topic: Multiple sclerosis
Layout: Freeze-dried in glass vial
Organism: Human
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification: No

Further Information to Islet amyloid polypeptide 64-78, GQVELGGGNAVEVLK

Information Values
Sequence: H-GQVELGGGNAVEVLK-OH
Specifications: 15mer peptide as TFA salt
Loading...

Check our list of products, click and go.

Get a quote